ZOMZomedica Corp.

NYSE zomedica.com


$ 0.14 $ 0.00 (-0.21 %)    

Friday, 05-Jul-2024 15:51:29 EDT
QQQ $ 495.80 $ 5.12 (1.04 %)
DIA $ 393.71 $ 0.87 (0.22 %)
SPY $ 554.29 $ 3.18 (0.58 %)
TLT $ 92.56 $ 0.76 (0.83 %)
GLD $ 220.89 $ 2.94 (1.35 %)
$ 0.145
$ 0.14
$ 0.00 x 0
$ 0.00 x 0
$ 0.14 - $ 0.14
$ 0.12 - $ 0.25
2,358,945
na
142.09M
$ 1.15
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 04-01-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-15-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-01-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 02-26-2020 12-31-2019 10-K
19 11-12-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-10-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 11-13-2018 09-30-2018 10-Q
24 08-09-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 02-28-2018 12-31-2017 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

https://x.com/TheRoaringKitty/status/1806371920495186041 

 zomedica-launches-new-cortisol-assay-for-equine-health-on-truforma-platform

 Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and t...

 zomedica-presents-truformar-research-findings-at-major-veterinary-internal-medicine-conference-says--new-research-data-confirms-superiority-of-truformas-bulk-acoustic-wave-sensor-technology-in-diagnosing-feline-hyperthyroidism

The firm announced the presentation of research highlighting the improved diagnostic capabilities of the TRUFORMA® Bulk Acousti...

 zomedica-continues-to-expect-fy24-revenue-of-31m-35m-est-341m

The outlook represents an increase of approximately 39% at the high end of the range, over full year 2023 revenue of $25.2 mill...

 zomedica-secures-ce-certification-for-vetguardian-expanding-access-to-contactless-monitoring-for-vets-in-the-eu

Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care dia...

 zomedica-q4-2023-gaap-eps-002-sales-7337m-beat-7000m-estimate

Zomedica (AMEX:ZOM) reported quarterly losses of $(0.02) per share. The company reported quarterly sales of $7.337 million whi...

 earnings-scheduled-for-april-1-2024

Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per...

 zomedica-says-continuing-dialogue-with-senior-regulatory-staff-at-nyse-american-regarding-next-steps-to-regaining-compliance-with-its-listing-standards

Zomedica shares will remain listed on the NYSE American at this time. A Special Meeting of Shareholders was held on February 28...

 zomedica-announces-1-for-80-reverse-stock-split

Seeking Approval for 80 - 1 Reverse Stock SplitAs announced on January 10, 2024, the Company will be holding a Special Virtual-...